Cell Reports Medicine

Scope & Guideline

Transforming discoveries into medical advancements for all.

Introduction

Welcome to the Cell Reports Medicine information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Cell Reports Medicine, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2666-3791
PublisherCELL PRESS
Support Open AccessYes
CountryUnited States
TypeJournal
Convergefrom 2020 to 2024
AbbreviationCELL REP MED / Cell Rep. Med.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139

Aims and Scopes

Cell Reports Medicine aims to publish high-quality research that advances the understanding of medicine through innovative studies and methodologies. The journal's focus encompasses a wide range of biomedical fields, emphasizing translational research that bridges laboratory findings with clinical applications.
  1. Translational Medicine:
    The journal emphasizes studies that translate basic research findings into clinical practice, promoting innovations that can directly benefit patient care.
  2. Multi-Omics Approaches:
    Research utilizing integrated multi-omics methodologies (genomics, proteomics, metabolomics) to explore complex biological systems and disease mechanisms is a key focus area.
  3. Cancer Research:
    A significant portion of the published works addresses cancer biology, including therapeutic strategies, biomarker discovery, and immunotherapy advancements.
  4. Immunology and Infection:
    The journal features studies on immune responses, host-pathogen interactions, and vaccine development, particularly in the context of emerging infectious diseases.
  5. Personalized Medicine:
    Research aimed at understanding individual variability in response to treatment and the development of personalized therapeutic strategies is highlighted.
  6. Microbiome Research:
    Investigations into the role of microbiota in health and disease, including their interactions with the immune system and implications for therapeutic interventions, are prevalent.
Recent publications in Cell Reports Medicine indicate a dynamic evolution of research themes, reflecting the journal's adaptation to the latest scientific advancements and public health needs. Emerging topics highlight the integration of innovative methodologies and interdisciplinary approaches.
  1. Artificial Intelligence in Medicine:
    The application of AI and machine learning for diagnostics, treatment prediction, and personalized medicine is rapidly gaining traction, as evidenced by an increasing number of publications.
  2. Immunotherapy and Cancer Vaccines:
    Research exploring novel immunotherapeutic strategies, including CAR T-cell therapy and vaccine development for cancer treatment, is on the rise.
  3. Gut-Brain Axis and Metabolism:
    Studies examining the interactions between the gut microbiome and neurobiology, particularly in relation to metabolic diseases and mental health, are becoming more prominent.
  4. Long COVID and Post-Acute Sequelae:
    Research focused on the long-term effects of COVID-19, including immune responses and therapeutic interventions for post-acute sequelae, has emerged as a critical area.
  5. Gene Editing and CRISPR Technologies:
    Innovations in gene editing technologies, particularly CRISPR applications for therapeutic purposes, are increasingly featured, reflecting advancements in genetic medicine.

Declining or Waning

While Cell Reports Medicine continues to explore a diverse array of biomedical topics, certain themes have shown signs of declining prominence in recent publications. This may reflect shifting research priorities or emerging areas of interest within the field.
  1. Traditional Pharmacology:
    Research focused solely on conventional pharmacological approaches without integrating modern techniques such as genomics or proteomics appears to be less frequently published.
  2. Basic Science without Clinical Relevance:
    Papers that do not establish a clear connection between laboratory findings and clinical implications are becoming less common, as the journal prioritizes translational research.
  3. Single-Disciplinary Studies:
    There is a noticeable decrease in studies that focus exclusively on one discipline (e.g., pure biology or chemistry) without interdisciplinary approaches, as the journal seeks comprehensive insights.

Similar Journals

Byulleten Sibirskoy Meditsiny

Advancing Molecular Medicine Through Open Access Research
Publisher: SIBERIAN STATE MEDICAL UNIVISSN: 1682-0363Frequency: 6 issues/year

Byulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.

Journal of Translational Medicine

Transforming Research into Real-World Impact.
Publisher: BMCISSN: Frequency: 1 issue/year

Journal of Translational Medicine, published by BMC in the United Kingdom, stands at the forefront of biomedical research, bridging the gap between laboratory discoveries and clinical applications. Established in 2003 as an Open Access journal, it has garnered significant recognition, achieving a Q1 quartile ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories as of 2023. With an impressive Scopus rank of 38 out of 636 in General Medicine and 33 out of 221 in General Biochemistry, Genetics and Molecular Biology, the journal is committed to disseminating high-quality, peer-reviewed research that impacts healthcare and informs clinical practices. By facilitating free access to groundbreaking studies, the Journal of Translational Medicine aims to enhance collaboration among researchers, professionals, and students in the scientific community, fostering advancements in translational research well into the future.

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Advancing the Frontiers of Biological and Medical Research
Publisher: SPRINGERISSN: 0007-4888Frequency: 12 issues/year

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE is a prestigious journal published by SPRINGER, dedicated to advancing knowledge in the fields of biochemistry, genetics, molecular biology, and medicine. Established in 1956 and continuing to be relevant through to 2024, this journal provides a vital platform for researchers to publish original findings and significant reviews that contribute to these essential disciplines. With an ISSN of 0007-4888 and an E-ISSN of 1573-8221, it enjoys a respectable standing in the academic community, currently positioned in the Q3 quartile of both Biochemistry, Genetics and Molecular Biology, and Medicine categories for 2023. Despite its traditional subscription model, the journal reaches a wide audience of professionals, students, and researchers, who benefit from timely access to impactful research and experimental studies. By fostering a rich dialogue in experimental biology and medicine, this journal plays an important role in shaping ongoing research and understanding of complex biological systems.

M S-MEDECINE SCIENCES

Unveiling critical advancements in biochemistry and medicine.
Publisher: EDP SCIENCES S AISSN: 0767-0974Frequency: 12 issues/year

M S-MEDECINE SCIENCES, published by EDP SCIENCES S A, is an esteemed journal based in France dedicated to the fields of biochemistry, genetics, and medicine. With an ISSN of 0767-0974 and an E-ISSN of 1958-5381, this journal has been a platform for scholarly communication since its inception in 1990 and continues to present critical advancements in these scientific domains, aiming to bridge theoretical research with practical applications. Despite its current Q4 ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories, the journal aspires to enhance its visibility and impact within the academic community. Researchers and professionals can benefit from a wealth of studies that contribute to the understanding of complex biological systems and medical innovations. Interested authors are encouraged to explore the journal's submission guidelines and contribute to the growing body of knowledge in these important fields.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Exploring the Foundations of Health and Disease
Publisher: ELSEVIERISSN: 0925-4439Frequency: 12 issues/year

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, published by Elsevier, is a pivotal journal in the fields of Molecular Biology and Molecular Medicine, recognized for its high impact factor and robust ranking within Scopus categories, holding prestigious quartiles in Q1 for both disciplines as of 2023. With ISSN 0925-4439 and E-ISSN 1879-260X, this journal fosters cutting-edge research from 1990 to 2025, addressing the critical molecular mechanisms underlying human diseases. Its wide-ranging scope includes original research articles, reviews, and advanced theoretical insights, serving as an essential resource for researchers, clinicians, and students alike. The journal is based in the Netherlands, at RADARWEG 29, 1043 NX AMSTERDAM, and while it does not currently offer an open-access option, it continues to maintain a strong presence in the scientific community, enhancing our understanding of molecular processes in health and disease.

CYTOKINE & GROWTH FACTOR REVIEWS

Exploring the Dynamic Interplay of Biological Signals
Publisher: ELSEVIER SCI LTDISSN: 1359-6101Frequency: 6 issues/year

CYTOKINE & GROWTH FACTOR REVIEWS, published by Elsevier Science Ltd, serves as a premier platform for the dissemination of cutting-edge research in the fields of Biochemistry, Genetics and Molecular Biology, Endocrinology, and Immunology. With an impressive impact factor that places it in the Q1 category across multiple disciplines, the journal brings together high-quality reviews that critically evaluate recent advances in cytokine and growth factor biology. This ensures that researchers and professionals have access to valuable insights that enhance current knowledge and stimulate further investigation. Although it is not an open-access journal, its rigorous selection process and high ranking – including Rank #7 in Medicine: Endocrinology, Diabetes and Metabolism – underscore its significance within the scientific community. With its converged years of publication from 1996 to 2024, CYTOKINE & GROWTH FACTOR REVIEWS remains a crucial resource for students, researchers, and professionals alike, informing their work with comprehensive overviews of key topics in the dynamic interplay of growth factors and cytokines.

Molecular Medicine Reports

Bridging Laboratory Discoveries with Clinical Solutions
Publisher: SPANDIDOS PUBL LTDISSN: 1791-2997Frequency: 12 issues/year

Molecular Medicine Reports, an esteemed academic journal published by Spandidos Publications Ltd, serves as a vital platform for the dissemination of cutting-edge research in the field of molecular medicine. Established in 2008, this journal has rapidly ascended in prominence, currently positioned within the Q2 and Q3 quartiles across various critical categories including Biochemistry, Cancer Research, and Genetics, reflecting its significant impact and scholarly contributions. With an impressive Scopus ranking in multiple disciplines, including an 87th place in Oncology, it is recognized for publishing rigorous, peer-reviewed articles that bridge the gap between laboratory research and clinical applications. The journal’s commitment to advancing knowledge in molecular medicine is evident through its focus on innovative therapeutic approaches, genetic research, and oncological studies, catering to a diverse readership of researchers, professionals, and students in the biomedical field. Though not an open-access publication, it provides invaluable insights and fosters collaboration in the scientific community from its base in Athens, Greece.

Cell Discovery

Unveiling Breakthroughs in Life Sciences
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Cell Discovery, published by SPRINGERNATURE, is a premier open access journal in the dynamic fields of Biochemistry, Cell Biology, Genetics, and Molecular Biology. Since its inception in 2015, this journal has established itself as a key platform for disseminating high-impact research and is recognized with a Q1 ranking across all its core categories for the year 2023. With its remarkable Scopus rankings—7th in Genetics, 9th in Biochemistry, 13th in Molecular Biology, and 15th in Cell Biology—Cell Discovery positions itself among the elite journals in life sciences, showcasing the most innovative breakthroughs and comprehensive reviews. Based in the United Kingdom, this journal operates under an open access model, ensuring that groundbreaking discoveries are readily available to researchers, professionals, and students around the globe. With a commitment to advancing scientific knowledge, Cell Discovery welcomes contributions that push the frontiers of our understanding in cellular and genetic sciences.

Biomed Research International

Empowering global access to groundbreaking biomedical insights.
Publisher: HINDAWI LTDISSN: 2314-6133Frequency: 1 issue/year

Biomed Research International is a prominent open access journal published by HINDAWI LTD, dedicated to advancing the field of biomedical research. With its ISSN 2314-6133 and E-ISSN 2314-6141, this journal has been a significant contributor to the scientific community since its inception in 2013, making scholarly work accessible to a global audience. The journal's scope encompasses a range of disciplines, including biochemistry, genetics, molecular biology, immunology, microbiology, and medicine, reflecting its commitment to interdisciplinary research. Ranked in the Q2 quartile as of 2023 across several relevant categories, Biomed Research International is recognized for its high-quality publications that foster innovation and collaboration in biomedical studies. Researchers, professionals, and students looking to share and gain insights into cutting-edge biomedical discoveries will find this journal an essential resource. With a focus on rapid dissemination of research findings, the journal serves as a vital platform for academics to engage with contemporary issues in health and disease, ultimately contributing to the advancement of medical science.

Cold Spring Harbor Perspectives in Medicine

Fostering Dialogue for a Healthier Tomorrow
Publisher: COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPTISSN: 2157-1422Frequency: 12 issues/year

Cold Spring Harbor Perspectives in Medicine is a premier academic journal published by the esteemed COLD SPRING HARBOR LAB PRESS that has become a crucial resource in the fields of Biochemistry, Genetics, and Medicine. With an impressive impact factor and consistently ranked in the Q1 quartile for both biochemistry and general medicine—as evidenced by its Scopus rankings of #21 and #26 respectively—this journal serves as an essential platform for disseminating high-quality research and comprehensive reviews from leading experts. Covering a convergence of knowledge spanning from 2011 through 2024, it plays a vital role in advancing the understanding of medical science. Researchers, professionals, and students alike benefit from Cold Spring Harbor Perspectives in Medicine, which offers a depth of insight into critical topics, emerging trends, and essential developments within the medical community. Join the conversation and contribute to the ongoing dialogue that drives innovation and excellence in medical research.